Specifically, the odds ratio (ORs) for MS stood at 0.52 (95% CI 0.28–0.96) for IFI16 (interferon-inducible protein 16), 0.63 (95% CI 0.44–0.91) for BTG2 (BTG family member 2), and 0.82 (95% CI 0.74–0.91) for Fc receptor-like protein 3 (FCRL3) (Table 1; Supplementary Figures 2-4). Here, FCRL3 is linked to myeloid sarcoma.